Green Car Congress  
Home Topics Archives About Contact  RSS Headlines

« Enevate introduces its silicon-dominant Li-ion technology for EVs; extreme fast charging and high capacity | Main | BMW Group electrified vehicle sales account for 5.5% of total group sales in US »

Print this post

Fully autonomous vehicle developer Optimus Ride raises $18M in Series A

2 November 2017

Optimus Ride, a MIT spinoff company developing self-driving technology (earlier post), closed an $18-million Series A funding led by Greycroft Partners with participation from Emerson Collective, Fraser McCombs Capital and renowned venture capitalist and current director of MIT Media Lab, Joi Ito. Optimus Ride has raised a total of $23.25 million through two rounds of financing.

The company will immediately use the capital to scale its current vehicle fleet and make strategic hires as well as continue its efforts to educate the market of the potential of fully autonomous driving technology.

Earlier this year, Optimus Ride received approval from MassDOT to test highly automated vehicles in the Commonwealth of Massachusetts. In addition, the company signed a Memorandum of Understanding (MOU) with MassDOT along with the City of Boston to enable testing of self-driving vehicles on roads and public property in the City of Boston and the Commonwealth of Massachusetts, beginning in Raymond L. Flynn Marine Park.

November 2, 2017 in Brief | Permalink | Comments (0)

Comments

Verify your Comment

Previewing your Comment

This is only a preview. Your comment has not yet been posted.

Working...
Your comment could not be posted. Error type:
Your comment has been posted. Post another comment

The letters and numbers you entered did not match the image. Please try again.

As a final step before posting your comment, enter the letters and numbers you see in the image below. This prevents automated programs from posting comments.

Having trouble reading this image? View an alternate.

Working...

Post a comment

Green Car Congress © 2017 BioAge Group, LLC. All Rights Reserved. | Home | BioAge Group